Search Grant Opportunities

Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)

ID: RFA-DA-20-026 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.

Overview

Category of Funding
Education
Health
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 9/16/19 the National Institutes of Health posted grant opportunity RFA-DA-20-026 for Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed). The grant will be issued under grant program 93.279 Drug Abuse and Addiction Research Programs.

Timing

Posted Date
Sept. 16, 2019, 12:00 a.m. EDT
Closing Date
Jan. 15, 2020, 12:00 a.m. EST Past Due
Last Updated
Sept. 17, 2019, 9:29 a.m. EDT
Version
1
Archive Date
Feb. 20, 2020

Eligibility

Eligible Applicants
Native American tribal governments (Federally recognized)
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Special district governments
Small businesses
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
County governments
City or township governments
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 496-3405

Documents

Posted documents for RFA-DA-20-026

Grant Awards

Grants awarded through RFA-DA-20-026

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to RFA-DA-20-026

Experts for Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)

Recommended subject matter experts available for hire